7월 29일 · 실적분석
실적분석
Fortrea ($FTRE) Q2 2026 Earnings Analysis — Adjusted EPS and Revenue Beat Estimates, Full-Year Guidance Raised
FTRE Fortrea 실적 요약Fortrea ($FTRE) reported Q2 2026 adjusted diluted EPS of $0.23 and revenue of $678 million, beating consensus estimates of $0.18 and $648 million, respectively. On a GAAP basis, the company posted a $0.14 per-share loss, but the book-to-bill ratio stayed above 1.0x for a fourth straight quarter and full-year guidance was lifted. Shares traded higher in the after-hours session, reflecting the earnings surprise and improved outlook. The recovery in profitability within the clinical trial services business and ongoing bookings momentum are the key takeaways.
Earnings Scorecard
▸ Revenue: $678 million (-4.5% year-over-year; estimate $648 million) ✅ Beat
▸ EPS (Earnings Per Share): Adjusted diluted $0.23 (estimate $0.18) ✅ Beat
▸ Guidance: Raised — FY2026 revenue $2.62B–$2.69B; adjusted EBITDA $205M–$220M
▸ Stock reaction: After-hours +4.35% ($21.6) — as of 07-29 20:55 KST
The Positives
▸ Adjusted earnings beat: Adjusted diluted EPS of $0.23 came in above the $0.18 estimate
▸ Revenue surprise: Revenue of $678 million topped the $648 million estimate
▸ Bookings and guidance improvement: Book-to-bill of 1.06x; FY revenue and earnings outlook raised
Fortrea is a global contract research organization (CRO), and the quarter's adjusted diluted EPS of $0.23 was also higher than the prior-year $0.19. Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of $58.7 million also exceeded the prior-year $54.9 million, showing profitability metrics improved even as revenue declined.
On the bookings side, the quarterly book-to-bill ratio came in at 1.06x, with the trailing-twelve-month (TTM) ratio at 1.12x — marking four consecutive quarters above 1.0x — and the backlog stood at $7.8 billion as of the end of June. Building on this, the company raised its FY2026 revenue and adjusted EBITDA guidance ranges.
The Negatives
▸ Revenue down year-over-year: Down roughly 4.5% versus the prior-year $710 million
▸ GAAP loss: Diluted net loss per share of $0.14, creating a wide gap versus adjusted earnings
▸ First-half cash flow weakness: First-half free cash flow of -$5.1 million, with volatility
The absolute revenue figure declined from a year earlier. Q2 revenue of $678 million fell short of the prior-year $710 million, and first-half revenue of $1.315 billion was also lower than the prior-year $1.362 billion. Setting aside the beat versus expectations, the pace of top-line recovery still needs to be confirmed.
On a GAAP basis, the company recorded a Q2 net loss of $13.2 million, or $0.14 per diluted share. Since the comparison basis differs from adjusted earnings, a direct apples-to-apples comparison is difficult, but the gap between the figure excluding one-time and non-cash items and the statutory profit-and-loss number is an area that can easily confuse novice investors. Operating cash flow was positive in the first half, but free cash flow was negative, making the stability of cash generation another area to monitor going forward.
What Management Said
"Our second-quarter results reflect continued progress against our strategy and disciplined execution across the business." — Anshul Thakral, Chief Executive Officer
"We delivered solid operational and financial performance, achieved a book-to-bill ratio above 1.0x for a fourth consecutive quarter, and raised our full-year 2026 guidance, reflecting our confidence in the business." — Anshul Thakral, Chief Executive Officer
CEO Anshul Thakral characterized the Q2 results as demonstrating progress in strategic execution and disciplined execution. He pointed to four consecutive quarters of book-to-bill above 1.0x and the full-year guidance raise as evidence of confidence, with a clear tone of maintaining commercial execution, operational efficiency, and financial discipline to drive sustainable growth and margin expansion.
The guidance raise sent a message to the market beyond the numbers themselves — that "execution is becoming visible." However, the annual outlook only provided ranges for revenue and adjusted EBITDA, and the press release did not include quarterly detailed guidance. The market's next focus appears to be whether the bookings momentum translates into an actual revenue rebound and cash generation.
Market Reaction and Key Points Ahead
The combination of adjusted earnings and revenue beating market expectations, together with a raise to full-year guidance, was read as drawing buying interest into the after-hours session. Rather than the disappointment of a year-over-year revenue decline, the market read a stronger "turnaround narrative" of improving profitability, recovering bookings, and a raised outlook. Given the relatively small market cap, the stock also tends to be more sensitive to earnings surprises.
▸ Monitor whether the book-to-bill ratio is sustained or expanded above 1.0x in the next quarter.
▸ Watch whether revenue transitions from a year-over-year decline back to stability or a rebound.
▸ Check whether margins and free cash flow actually keep pace with the raised full-year guidance.
면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.
🎯 오늘의 AI 픽 5종목, 무료로 전부 공개합니다
숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다